share_log

Virios Therapeutics Q4 2023 GAAP EPS $(0.06) Beats $(0.09) Estimate

Moomoo 24/7 ·  Feb 29 09:17

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment